High-intensity thromboprohylaxis is not associated with reductions in COVID-19 worsening, severe disease, or deathCorey Joseph, Kayte M. Andersen,Hemalkumar Mehta,Michael B. Streiff,Joshua Betz,Robert C. Bollinger,Arielle Fisher,Amita Gupta,Charles F. LeMaistre,Matthew Robinson,Yanxun Xu,Derek K. Ng,G. Caleb Alexander,Brian GaribaldiPHARMACOEPIDEMIOLOGY AND DRUG SAFETY（2022）引用 0|浏览18暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
